⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for bladder small cell neuroendocrine carcinoma

Every month we try and update this database with for bladder small cell neuroendocrine carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsNCT02496208
Bladder Small C...
Bladder Squamou...
Bladder Urothel...
Clear Cell Rena...
Invasive Bladde...
Invasive Bladde...
Invasive Sarcom...
Kidney Medullar...
Malignant Genit...
Malignant Solid...
Penile Carcinom...
Penile Squamous...
Renal Cell Carc...
Renal Pelvis Ur...
Sarcomatoid Ren...
Stage III Bladd...
Stage III Penil...
Stage III Renal...
Stage III Renal...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IV Bladde...
Stage IV Penile...
Stage IV Renal ...
Stage IV Renal ...
Stage IV Ureter...
Stage IV Urethr...
Ureter Urotheli...
Urethral Urothe...
Biopsy
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsNCT02496208
Bladder Small C...
Bladder Squamou...
Bladder Urothel...
Clear Cell Rena...
Invasive Bladde...
Invasive Bladde...
Invasive Sarcom...
Kidney Medullar...
Malignant Genit...
Malignant Solid...
Penile Carcinom...
Penile Squamous...
Renal Cell Carc...
Renal Pelvis Ur...
Sarcomatoid Ren...
Stage III Bladd...
Stage III Penil...
Stage III Renal...
Stage III Renal...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IV Bladde...
Stage IV Penile...
Stage IV Renal ...
Stage IV Renal ...
Stage IV Ureter...
Stage IV Urethr...
Ureter Urotheli...
Urethral Urothe...
Biopsy
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the LungsNCT03896503
Bladder Small C...
Extensive Stage...
Extrapulmonary ...
Limited Stage L...
Platinum-Resist...
Platinum-Sensit...
Prostate Small ...
Recurrent Lung ...
Berzosertib
Biopsy
Biospecimen Col...
Computed Tomogr...
Topotecan Hydro...
18 Years - National Cancer Institute (NCI)
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the LungsNCT03896503
Bladder Small C...
Extensive Stage...
Extrapulmonary ...
Limited Stage L...
Platinum-Resist...
Platinum-Sensit...
Prostate Small ...
Recurrent Lung ...
Berzosertib
Biopsy
Biospecimen Col...
Computed Tomogr...
Topotecan Hydro...
18 Years - National Cancer Institute (NCI)
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or ProstateNCT03582475
Bladder Small C...
Castration-Resi...
Metastatic Blad...
Metastatic Uret...
Prostate Carcin...
Prostate Neuroe...
Prostate Small ...
Stage III Bladd...
Stage III Prost...
Stage III Ureth...
Stage IV Bladde...
Stage IV Prosta...
Stage IV Urethr...
Stage IVA Bladd...
Stage IVB Bladd...
Ureter Small Ce...
Urothelial Carc...
Carboplatin
Cisplatin
Docetaxel
Etoposide
Pembrolizumab
18 Years - Jonsson Comprehensive Cancer Center
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsNCT03866382
Bladder Adenoca...
Bladder Clear C...
Bladder Mixed A...
Bladder Neuroen...
Bladder Small C...
Bladder Squamou...
Chromophobe Ren...
Collecting Duct...
Invasive Bladde...
Invasive Bladde...
Invasive Bladde...
Invasive Bladde...
Invasive Bladde...
Invasive Bladde...
Kidney Medullar...
Large Cell Neur...
Malignant Testi...
Malignant Testi...
Metastatic Blad...
Metastatic Blad...
Metastatic Blad...
Metastatic Blad...
Metastatic Blad...
Metastatic Blad...
Metastatic Blad...
Metastatic Blad...
Metastatic Blad...
Metastatic Blad...
Metastatic Chro...
Metastatic Kidn...
Metastatic Mali...
Metastatic Papi...
Metastatic Peni...
Metastatic Pros...
Metastatic Sarc...
Metastatic Uret...
Papillary Renal...
Sarcomatoid Ren...
Stage IV Bladde...
Stage IV Penile...
Stage IV Renal ...
Stage IV Urethr...
Stage IVB Prost...
Urachal Adenoca...
Urethral Clear ...
Bone Scan
Cabozantinib S-...
Computed Tomogr...
Ipilimumab
Magnetic Resona...
Nivolumab
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: